ACTIVE

NOVARTIS PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

11,5 M €

-14.2% YoY

Revenue

378,6 M €

+6.2% YoY

Equity

32,1 M €

-31.8% YoY

Workforce

207,8 ETP

-1.1% YoY

What does NOVARTIS PHARMA do?

NOVARTIS PHARMA is a Public limited company incorporated in 1996. Its registered office is in Machelen (Brab.). It employs on average 207,8 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0459.093.476

Incorporation

25/10/1996

Legal form

Public limited company

Registered office

Kouterveldstraat 2
1831 Machelen (Brab.) · FlandreSee on map

Contributed capital

10 170 314,07 €

Latest accounts

31/12/2025

Average workforce

207,8 ETP

Joint committees (2)

Signals

ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 15 financial years

	2025		2024		2023		2022		2020		2019		2018		2015		2014		2013		2012		2011		2010		2009		2008
Income statement
Revenue	378,6 M €	+6.2%	356,5 M €	+4.7%	340,6 M €	+5.1%	324 M €	+2.8%	315,2 M €	-1.5%	320,1 M €	+0.2%	319,6 M €	+21.7%	262,7 M €	+9.7%	239,5 M €	+0.5%	238,2 M €	+1.9%	233,8 M €	-1.4%	237,2 M €	+4.8%	226,4 M €	+8.2%	209,3 M €	+9.6%	190,9 M €
EBITDA	12,1 M €	-27.4%	16,7 M €	-37.2%	26,5 M €	+2728%	937,8 k €	-88.4%	8,1 M €	+15.0%	7 M €	+56.8%	4,5 M €	-16.0%	5,3 M €	-10.7%	6 M €	-14.7%	7 M €	+7.1%	6,5 M €	+115%	3 M €	-71.2%	10,5 M €	+3.4%	10,1 M €	+112%	4,8 M €
Operating result	15 M €	+6.7%	14 M €	-52.2%	29,3 M €	+515%	4,8 M €	-45.3%	8,7 M €	+32.1%	6,6 M €	+23.1%	5,4 M €	+35.1%	4 M €	-41.5%	6,8 M €	+18.2%	5,7 M €	-1.3%	5,8 M €	+83.8%	3,2 M €	-67.2%	9,6 M €	-2.8%	9,9 M €	+0.7%	9,9 M €
Net result	11,5 M €	-14.2%	13,4 M €	-48.5%	26,1 M €	+878%	-3,4 M €	-279%	1,9 M €	-58.9%	4,6 M €	+87.1%	2,4 M €	-2.1%	2,5 M €	-34.3%	3,8 M €	-37.7%	6,1 M €	+500%	1 M €	+469%	-275 k €	-103%	8,1 M €	-19.1%	10 M €	+10.7%	9 M €
Balance sheet
Equity	32,1 M €	-31.8%	47,1 M €	+39.9%	33,7 M €	-53.6%	72,6 M €	+552%	11,1 M €	-0.2%	11,2 M €	-45.5%	20,5 M €	-36.9%	32,5 M €	-4.4%	34 M €	-0.6%	34,2 M €	+21.6%	28,1 M €	+3.7%	27,1 M €	-1.0%	27,4 M €	+41.9%	19,3 M €	+107%	9,3 M €
Total assets	168,8 M €	+11.1%	151,9 M €	-6.2%	162 M €	-0.9%	163,4 M €	+15.6%	141,4 M €	+15.4%	122,5 M €	+10.3%	111,1 M €	-1.1%	112,3 M €	+33.3%	84,2 M €	-3.8%	87,5 M €	+17.6%	74,4 M €	-11.4%	84 M €	-3.2%	86,7 M €	+17.3%	73,9 M €	-6.4%	79 M €
Cash	67,2 k €	-0.3%	67,4 k €	-0.1%	67,5 k €	-54.8%	149,5 k €	+406%	29,5 k €	+6.0%	27,9 k €	+80.5%	15,4 k €	-50.0%	30,9 k €	+39.9%	22 k €	-40.5%	37,1 k €	+109%	17,7 k €	-98.6%	1,3 M €	+142%	533,2 k €	-26.5%	725,8 k €	+380%	151,3 k €
Debts	132,2 M €	+37.0%	96,5 M €	-7.2%	103,9 M €	+114%	48,5 M €	-52.6%	102,2 M €	+4.7%	97,6 M €	+46.6%	66,6 M €	+5.3%	63,2 M €	+57.5%	40,1 M €	-5.4%	42,4 M €	+14.7%	37 M €	-25.5%	49,6 M €	-3.6%	51,5 M €	+16.7%	44,1 M €	-30.2%	63,2 M €
Other
Workforce	207,8 ETP	-1.1%	210,1 ETP	-9.2%	231,4 ETP	-17.3%	279,8 ETP	-12.4%	319,4 ETP	-2.1%	326,3 ETP	-2.4%	334,2 ETP	+12.9%	296,1 ETP	+4.0%	284,6 ETP	+2.0%	278,9 ETP	-2.6%	286,4 ETP	-5.5%	303,2 ETP	-0.9%	306,1 ETP	+4.2%	293,9 ETP	+1.9%	288,3 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 26 ended

Active mandates

Nicolas ISTAS

Director · since 01 juillet 2022 · until 30 juin 2028

Active

Andrea MAJOCCHI

Director · since 01 mars 2022 · until 28 février 2028

Active

Federico MAMBRETTI

Director · since 21 septembre 2021 · until 21 septembre 2027

Active

Ended mandates

Nicolas Thiriet

Director · since 06 juin 2019 · until 06 juin 2025

Ended

Mark Never

Director · since 01 novembre 2017 · until 06 juin 2023

Ended

Philippe de Pougnadoresse

Director · since 01 juin 2017 · until 06 juin 2023

Ended

Dario Drago

Chairman of the board of directors · since 07 décembre 2016 · until 06 juin 2023

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	05/06/2026	06/06/2025	06/06/2024	07/06/2023	03/06/2022	26/10/2021
General meeting	04/06/2026	05/06/2025	06/06/2024	01/06/2023	02/06/2022	03/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	04/06/2026	05/06/2026	Dutch	PDF
Full model	31/12/2024	05/06/2025	06/06/2025	Dutch	PDF
Full model	31/12/2023	06/06/2024	06/06/2024	Dutch	PDF
Full model	31/12/2022	01/06/2023	07/06/2023	Dutch	PDF
Full model	31/12/2021	02/06/2022	03/06/2022	Dutch	PDF
Full modelCorrection	31/12/2020	03/06/2021	26/10/2021	Dutch	PDF
Full model	31/12/2020	03/06/2021	17/06/2021	Dutch	PDF
Full model	31/12/2019	04/06/2020	12/06/2020	Dutch	PDF
Full model	31/12/2018	06/06/2019	07/06/2019	Dutch	PDF
Full model	31/12/2017	07/06/2018	12/06/2018	Dutch	PDF
Full model	31/12/2016	01/06/2017	07/07/2017	Dutch	PDF
Full model	31/12/2015	02/06/2016	27/06/2016	Dutch	PDF
Full model	31/12/2014	04/06/2015	07/07/2015	Dutch	PDF
Full model	31/12/2013	05/06/2014	12/06/2014	Dutch	PDF
Full model	31/12/2012	06/06/2013	20/06/2013	Dutch	PDF
Full model	31/12/2011	07/06/2012	12/12/2012	Dutch	PDF
Full model	31/12/2010	06/06/2011	26/07/2011	Dutch	PDF
Full model	31/12/2009	03/06/2010	13/07/2010	Dutch	PDF
Full model	31/12/2008	26/06/2009	16/07/2009	Dutch	PDF
Full model	31/12/2007	05/06/2008	11/07/2008	Dutch	PDF
Full model	31/12/2006	07/06/2007	22/06/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 26 ended

Active mandates

Nicolas ISTAS

Director · since 01 juillet 2022 · until 30 juin 2028

Active

Andrea MAJOCCHI

Director · since 01 mars 2022 · until 28 février 2028

Active

Federico MAMBRETTI

Director · since 21 septembre 2021 · until 21 septembre 2027

Active

Ended mandates

Nicolas Thiriet

Director · since 06 juin 2019 · until 06 juin 2025

Ended

Mark Never

Director · since 01 novembre 2017 · until 06 juin 2023

Ended

Philippe de Pougnadoresse

Director · since 01 juin 2017 · until 06 juin 2023

Ended

Dario Drago

Chairman of the board of directors · since 07 décembre 2016 · until 06 juin 2023

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates17/09/2026
Ontslag - Benoeming Bestuurders - Volmacht
PDF
Registered office15/05/2026
MAATSCHAPPELIJKE ZETEL
PDF
Registered office27/04/2026
MAATSCHAPPELIJKE ZETEL
PDF
Mandates22/09/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates26/06/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/08/2023
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares20/06/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
PDF
Capital / shares02/01/2023
KAPITAAL - AANDELEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202511,5 M €↓
27/08/2025
nominationFederico Mambretti — bijzondere volmacht
27/08/2025
nominationAndrea Majocchi — bijzondere volmacht
27/08/2025
nominationNicolas Istas — bijzondere volmacht
27/08/2025
nominationThomas Chretien — bijzondere volmacht
27/08/2025
nominationMarlies Engelen — bijzondere volmacht
05/06/2025
reconductionKPMG Bedrijfsrevisoren BV — commissaris
2024
Annual accounts 202413,4 M €↓
2023
Annual accounts 202326,1 M €↑
07/07/2023
demissionRebecca De Luca — bijzondere volmacht
07/07/2023
demissionPeter Gouverneur — bijzondere volmacht
07/07/2023
nominationFederico Mambretti — President Belgium and Luxembourg / bijzondere volmacht
07/07/2023
nominationAndrea Majocchi — CCFO Belgium and Luxembourg / bijzondere volmacht
07/07/2023
nominationNicolas Istas — Country Head of Legal Belgium and Luxembourg / bijzondere volmacht
07/07/2023
nominationRebecca De Luca — Business Excellence & Execution Head / bijzondere volmacht
07/07/2023
nominationPeter Gouverneur — KAM, Tendering & Established Brands Lea / bijzondere volmacht
15/06/2023
reduction_capital
2022
Annual accounts 2022-3,4 M €↓
19/12/2022
augmentation_capital
01/07/2022
nominationNicolas Istas — bestuurder
02/06/2022
nominationKPMG Bedrijfsrevisoren BV — commissaris
01/03/2022
nominationNicola Bencini — bestuurder
01/03/2022
nominationAndrea Majocchi — bestuurder
03/05/2021
demissionPhilippe de Pougnadoresse — bijzondere volmacht
03/05/2021
demissionNicolas Thiriet — bijzondere volmacht
03/05/2021
demissionMichel Geelhand — bijzondere volmacht
03/05/2021
demissionNicolas Istas — bijzondere volmacht
2020
Annual accounts 20201,9 M €↓
2019
Annual accounts 20194,6 M €↑
2018
Annual accounts 20182,4 M €↓
2015
Annual accounts 20152,5 M €↓
2014
Annual accounts 20143,8 M €↓
2013
Annual accounts 20136,1 M €↑
2012
Annual accounts 20121 M €↑
2011
Annual accounts 2011-275 k €↓
2010
Annual accounts 20108,1 M €↓
2009
Annual accounts 200910 M €↑
2008
Annual accounts 20089 M €
25/10/1996
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

NOVARTIS PHARMA

Overview

What does NOVARTIS PHARMA do?

Trend over 15 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline